Abstract
Probenecid inhibits the efflux of acid monoamine (MA) metabolites from the CNS. The probenecid-induced accumulation of these metabolites in the CSF in man supplies data on the central turnover of the corresponding amines. In this study an attempt was made to establish whether probenecid also exerts an influence on the metabolism of the MA precursors: tryptophan and tyrosine. The principal conclusions were the following.
-
1.
Whereas in rats probenecid lowers the serum tryptophan level and elevates that in the brain (probably as a result of interference with the binding of tryptophan to serum albumins), the serum tryptophan level in human individuals is also lowered but the CSF concentration remains unchanged. After an oral tryptophan load, however, the CSF tryptophan concentration does increase.It is suggested that in man, endogenously released and exogenous tryptophan enter different metabolic pools in the brain.
-
2.
After an oral load of 1-tryptophan, for the most part depressive patients showed a more rapid increase in CSF tryptophan concentration and a less marked rise of the CSF 5-HIAA level than did the psychologically undisturbed test subjects examined by Eccleston et al. It seems possible that, in the depressive patient, the tryptophan-metabolizing capacity is disturbed.
-
3.
After an oral load of 1-tryptophan the CSF HVA concentration increased. Possibly, tryptophan is transformed to 5-HT in dopaminergic neurons, and this 5-HT may supersede the DA from the storage sites. This effect may well be of significance in the therapeutic application of 5-HT precursors.
-
4.
The CSF concentrations of 5-HIAA, HVA, tryptophan and tyrosine show no systematic variations during the day.
Similar content being viewed by others
References
Barkai, A., Glusman, M., Rapport, M. M.: Serotonin turnover in the intact cat brain. J. Pharmacol. exp. Ther. 181, 28–35 (1972)
Bowers, M. B., Jr.: 5-HT metabolism in psychiatric syndromes. Lancet 1970II, 1029
Bowers, M. B., Jr.: Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures. Neuropharmacology 11, 101–111 (1972)
Butcher, L., Engel, J., Fuxe, K.: l-Dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J. Pharm. Pharmacol. 22, 313–316 (1970)
Carroll, B. J.: Monoamine precursors in depression: Clinical trials and theoretical implications. Comm. Contemp. Psychiat. 1, 87–94 (1971)
Dunner, D. L., Goodwin, F.K.: Effect of l-tryptophan on brain serotonin metabolism in depressed patients. Arch. gen. Psychiat. 26, 364–366 (1972)
Eccleston, D., Ashcroft, G. W., Crawford, T. B. B., Stanton, J. B., Wood, D., McTurk, P. H.: Effect of tryptophan administration on 5-HIAA in cerebrospinal fluid in man. J. Neurol. Neurosurg. Psychiat. 33, 269–272 (1970)
Fernstrom, J. D., Wurtman, R. J.: Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173, 149–152 (1971)
Goodwin,F. K.: State dependent as state independent biological variables in affective illness. Paper read for the 8th Congress of the Collegium Internationale Neuropsychopharmacologicum. Kopenhagen 1972
Goodwin, F. K., Dunner, D. L., Gershon, E. S.: Effect of l-dopa treatment on brain serotonin metabolism in depressed patients. Life Sci. 10, 751–759 (1971)
Grahame-Smith, D. G.: Tryptophan hydroxylase and regulation of indole formation: In: Serotonin and behaviour. Ed. by J. Barches and S. Usdin. New York and London: Academic Press 1972
Guldberg, H. C., Ashcroft, G. W., Crawford, T. B. B.: Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid. Life Sci. 5, 1571–1575 (1966)
Korf, J.: Amine metabolism in the human brain: Evaluation of the probenecid test. Diss., Groningen 1971
Korf, J., Ottema, S., Veen, I. van der: Fluorimetric determination of homovanillic acid in biological material after isolation on sephadex G-10. Analyt. Biochem. 40, 187–191 (1971)
Korf, J., Praag, H. M. van: Amine metabolism in human brain: further evaluation of the probenecid test. Brain Res. 35, 221–230 (1971)
Korf, J., Praag, H. M. van, Sebens, J. B.: Effect of intravenously administrated probenecid in humans on the levels of 5-hydroxy-indoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in cerebrospinal fluid. Biochem. Pharmacol. 20, 659–668 (1971)
Korf, J., Praag, H. M. van, Sebens, J. B.: Serum tryptophan decreased, brain tryptophan increased and brain serotonin synthesis unchanged after probenecid loading. Brain Res. 42, 239–242 (1972)
Lakke, J. P. W. F., Korf, J., Hoorntje, S., Praag, H. M. van, Schut, T.: The probenecid test in Parkinson's disease. Psychiat. Neurol. Neurochir. (Amst.) 76, 139–146 (1973)
Lakke, J. P. W. F., Korf, J., Praag, H. M. van, Schut, T.: The predictive value of the probenecid test for the effect of levodopa therapy in Parkinson's disease. Nature New Biol. 236, 208–209 (1972)
Lichtensteiner, W., Mutzner, U., Langemann, H.: Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines. J. Neurochem. 14, 489–497 (1967)
Neff, N. H., Tozer, T. N., Brodie, B. B.: Application of steady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J. Pharmacol. exp. Ther. 158, 214–218 (1967)
Ng, L. K. Y., Chase, T. N., Colburn, R. W., Kopin, I. J.: l-Dopa induced release of cerebral monoamines. Science 170, 76–77 (1970)
Ng, L. K. Y., Chase, T. N., Colburn, R. W., Kopin, I. J.: Release of (3H)dopamine by l-5-hydroxytryptophan. Brain Res. 45, 499–505 (1972)
Olsson, R., Roos, B.-E.: Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature (Lond.) 219, 502–503 (1968)
Praag, H. M. van: Depressie en de stofwisseling van 5-hydroxytryptamine. Ned. T. Geneesk. 113, 2245–2247 (1969)
Praag, H. M. van, Korf, J., Puite, J.: 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (Lond.) 225, 1259–1260 (1970)
Praag, H. M. van, Korf, J.: A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol. Psychiat. 3, 105–112 (1971)
Praag, H. M. van, Korf, J.: Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification? Psychopharmacologia (Berl.) 19, 148–152 (1971)
Praag, H. M. van, Korf, J., Dols, L. C. W., Schut, T.: A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia (Berl.) 25, 14–21 (1972)
Praag, H. M. van, Korf, J., Schut, T.: Cerebral monoamines and depression. An investigation into their correlation with the aid of the probenecid technique. Arch. gen. Psychiat. 28, 827–831 (1973)
Roos, B.-E., Sjöström, R.: 5-Hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patients with manic-depressive psychosis. Pharmacol. Clin. 1, 153–155 (1969)
Schutte, H. H., Berg, C. J. van den, Jonkheid van der Veen, I.: The use of analogue Computer stimulation in the study of compartmentation and turnover of 5-hydroxytryptamine in rat brain after labelling plasma tryptophan. Psychopharmacologia (Berl.) 26, 47 (1972)
Shields, P. J., Eccleston, D.: Effects of electrial stimulation of rat midbrain on 5-hydroxytryptamine synthesis as determined by a sensitive radioisotope method. J. Neurochem. 19, 265–272 (1972)
Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J., Stern, S.: Effect of psychotropic drugs on tryptophan concentration in the rat brain. J. Pharmacol. exp. Ther. 177, 475–480 (1971)
Tamarkin, N. R., Goodwin, F. K., Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, 1397–1408 (1970)
Werdinius, B.: Effect of probenecid on the levels of monoamine metabolites in the rat brain. Acta pharmacol. (Kbh.) 25, 18–23 (1967)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Praag, H.M., Flentge, F., Korf, J. et al. The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man. Psychopharmacologia 33, 141–151 (1973). https://doi.org/10.1007/BF00429084
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00429084